Method Validation for the Determination of Nicotine and Nicotine Metabolite Levels in Urine, Serum, and Saliva Samples
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Gülsüm Abuşoğlu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Techniques, Vocational School of Health Sciences Medical Services and Techniques Institution, Selcuk University, Kon…. Hauptthemen laut MEDLINE: Nicotine, Saliva. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Selçuk University Research Foundation.
Abstract (Originalsprache)
Monitoring nicotine and its metabolites in bodily fluids is crucial for assessing tobacco exposure and related toxicity in clinical practice. Due to its high sensitivity for detecting low‐level analytes, liquid chromatography–tandem mass spectrometry (LC–MS/MS) was employed to enhance a robust and accurate analytical procedure for quantifying nicotine and its derivatives in serum, urine, and saliva. Comparative analysis was conducted on samples collected from individuals with and without smoking habits. The LC–MS/MS method utilized an API 3200 triple quadrupole instrument paired with a Phenomenex Luna C18 column. Method sensitivity was demonstrated through evaluation of sensitivity parameters, including LOD and LLOQ for each analyte in all matrices. Inter‐assay variability and bias values at the LLOQ level were kept below 20%. In serum, the LOD–LLOQ ranges were 0.02–0.05 μg/L for nicotine, 0.32–0.95 μg/L for cotinine, 0.07–0.25 μg/L for 3‐OH cotinine, and 0.22–0.69 μg/L for norcotinine. In urine, the respective values were 0.03–0.10, 0.23–0.82, 0.06–0.14, and 0.20–0.55 μg/L, and in saliva, the values were 0.12–1.59, 0.22–2.34, 0.10–0.17, and 0.33–3.01 μg/L. The proposed method is efficient, specific, and adaptable to routine clinical workflows, providing a valuable tool for monitoring tobacco‐related exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Techniques, Vocational School of Health Sciences Medical Services and Techniques Institution, Selcuk University, Konya, Turkey.
- Department of Biochemistry, Faculty of Medicine, Bandırma Onyedi Eylül University, Konya, Turkey.
- Department of Biochemistry, Faculty of Medicine, Selcuk University, Konya, Turkey.
ORCID-Profile: Gülsüm Abuşoğlu
Förderung
- Selçuk University Research Foundation
Zitieren
APA
Abuşoğlu, G., Onmaz, D. E., Ünlü, A., Aydemir, F. H. Y., & Abuşoğlu, S. (2025). Method Validation for the Determination of Nicotine and Nicotine Metabolite Levels in Urine, Serum, and Saliva Samples. Biomedical Chromatography. https://doi.org/10.1002/bmc.70096
Vancouver
Abuşoğlu G, Onmaz DE, Ünlü A, Aydemir FHY, Abuşoğlu S. Method Validation for the Determination of Nicotine and Nicotine Metabolite Levels in Urine, Serum, and Saliva Samples. Biomedical Chromatography. 2025. doi:10.1002/bmc.70096
BibTeX
@article{Abuolu2025,
author = {Abuşoğlu, Gülsüm and Onmaz, Duygu Eryavuz and Ünlü, Ali and Aydemir, Fatma Hümeyra Yerlikaya and Abuşoğlu, Sedat},
title = {Method Validation for the Determination of Nicotine and Nicotine Metabolite Levels in Urine, Serum, and Saliva Samples},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70096}
}
EUVIMED